DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20193695

Study of outcome of the treatment with intravenous iron sucrose in moderately anaemic pregnant women

Kohila Kalimuthu, Vanusha Avudaithangam

Abstract


Background: Moderate anaemia seen in about 15-20% of pregnant women. Iron sucrose complex which is used intravenously for the correction of Iron deficiency anaemia. The drug has been able to raise the haemoglobin to satisfactory level when used in moderately anaemic iron deficient pregnant women. The objective of this study was to study the improvement of Hb% after treatment with intravenous Iron sucrose complex in moderately anaemic pregnant women belonging to 24-32 weeks of gestational age.

Methods: 50 antenatal patients between gestational age 24-32 weeks with hemoglobin between 8-9.5g/dl were selected and included in this study. They were subjected to blood hemoglobin estimation, hematocrit and peripheral smear study. In each infusion, the maximum total dose administered was 200 mg iron sucrose in 100 ml of normal saline, slow IV infused over 30 minutes. Monitoring was done throughout the infusion to observe for any side effects.

Results: Mean hemoglobin among the 50 patients before starting the therapy was 8.172g/dl and the mean hemoglobin at the end of one month of completing the therapy was 11.066g/dl. The rise in mean hemoglobin i.e. the difference in the mean hemoglobin before and after treatment was 2.894g/dl. The p value is 0.0001 which is statistically significant. The mean hematocrit of the 50 patients studied before starting the treatment was 26.772% with a standard deviation of 1.914. The mean hematocrit after completing the therapy was 33.872% with a standard deviation of 1.321. The difference in the mean hematocrit was 7.100% with a p value of 0.0001 which is statistically significant.

Conclusions: Intravenous iron sucrose complex is well tolerated and highly efficacious in improving hemoglobin, hematocrit in the treatment of iron deficiency anaemia in antenatal women.


Keywords


Haemoglobin, Hematocrit, Intravenous iron sucrose, Iron deficiency anaemia, Iron sucrose complex, Moderate anaemia

Full Text:

PDF

References


Mudaliar and Menon’s Clinical Obstetrics 12th Edition by Sarala Gopalan, S Rathnakumar, and Vanitha Jain; Orient Blackswan, Chapter 20; 2015:162.

Breymann C. Anemia working group. Current aspects of diagnosis and therapy of iron deficiency anemia in pregnancy. Schweiz Rundsch Med Prax. 2001;90:1283-91.

Kalaivani K. National institute of Health and Family welfare, Munirka- Use of intravenous iron sucrose for treatment of anaemia in pregnancy. The Indian J Med Res. 2013;138(1):16-7.

Kriplani A, Mahey R. Intravenous iron sucrose therapy for moderate to severe anaemia in pregnancy. Indian J Med Res. 2013;138(1):78-82.

Jose A, Mahey R, Kriplani A. Comparison of ferric carboxymaltose and iron sucrose complex for treatment of iron deficiency anemia in pregnancy. BMC Preg Childbirth. 2019;54:19.

Haldar P, Kant S. Effect of intravenous iron sucrose on haemoglobin level, when administered in a standard dose, to anemic pregnant women in rural northern India. J Family Med Primary Care. 2018;7(4):762-8.

Raja KS, Janjua NB, Khokhar N. Intravenous iron sucrose complex therapy in iron deficiency anemia in the pregnant women. Rawal Med J. 2003;28:40-3.

Dede A, Uygur D. At the Zakai Tahi Burak women’s health education and research hospital, division of perinatology, Turkey-Intravenous iron sucrose complex vs. oral ferrous sulfate for postpartum iron deficiency anemia. Int J Gynaecol Obstet. 2005;90(3):238-9.

Bhandal N, Russel R. Intravenous versus oral iron therapy for postpartum anaemia. BJOG. 2006;113(11):1248-52.

Qassim A, Mol BW, Grivell RM, Grzeskowiak LE. Safety and efficacy of intravenous iron polymaltose, iron sucrose and ferric carboxymaltose in pregnancy: A systematic review - Australian and New Zealand J Obstet Gynaecol. 2017;58(1).